Intractable Pain
Conditions
Keywords
Behavior therapy, Chronic pain, Cognitive therapy, Meditation, Mindfulness, Psychotherapy
Brief summary
The purpose of the study is to test a brief, group-administered psychosocial intervention to reduce interference of pain with daily life, emotional distress, and pain intensity, and improve quality of life and physical activity levels in individuals with chronic pain.
Detailed description
Chronic pain affects at least 15% of the veteran population and represents a high priority for the VA. In addition to primary pain conditions, chronic pain is a common secondary condition resulting from battlefield injuries, traumatic accidents, and congenital and acquired disorders. Unlike most forms of acute pain, treatment options available for patients suffering from chronic pain frequently offer only short-term or partial relief from symptoms. The focus of rehabilitative intervention thus becomes the reduction of disability and emotional distress and improvement in quality of life and activity levels. Chronic pain rehabilitation has evolved from a primarily one-dimensional, medically oriented approach to a multidisciplinary approach that incorporates a biopsychosocial formulation to pain management with physiological, cognitive, behavioral, and emotional components. This conceptualization of pain recognizes that multiple intervention modalities, including psychosocial approaches, are required when providing treatment to chronic pain patients. A relatively new psychosocial approach to chronic pain management and rehabilitation involves acceptance of pain-related experiences. The Acceptance-based Therapy (AT) model is based on the theory that attempts to escape, avoid, or control negative experiences that cannot be changed, such as chronic pain, may paradoxically contribute to the increased experience of them. Instead of seeking to control the negative experience, AT teaches individuals to use mindfulness strategies to enlarge the scope of experience beyond pain and to engage in behaviors that are consistent with personal values and goals when total elimination of pain or other negative experiences is not possible. Empirical support for acceptance-based approaches to chronic pain management is growing. Data from one of the first comparisons of AT to a well-established psychosocial intervention, Cognitive-Behavioral Therapy (CBT), performed at VASDHS by the PI, suggests that AT may be superior to CBT as an adjunctive treatment for chronic pain. The proposed study assembles a multidisciplinary team with extensive experience in chronic pain interventions research to evaluate the benefits of a brief, manualized group-administered psychosocial intervention which could be easily integrated into multidisciplinary pain rehabilitation programs throughout the VA system to reduce disability in veterans with chronic pain secondary to other conditions. Specifically, we propose to examine the effects of a promising new chronic pain intervention based on AT principles on the primary outcome of pain interference and secondary outcomes of emotional distress, quality of life, physical activity, pain intensity, and treatment satisfaction among 94 veterans with chronic benign pain as a secondary condition. The AT intervention will be compared with treatment as usual (TAU) in a within-subjects design and with CBT in a randomized, between-subjects design. Outcomes include an objective measure of physical activity, actigraphy, as well as self-reported measures and will be evaluated at baseline, 6 weeks (after a TAU phase), 12 weeks (after treatment), and at a 6-month follow-up period to investigate maintenance of gains. The study design also allows for an investigation of hypothesized mechanisms of change, acceptance (for AT) and perceived pain control (for CBT). Thus, the proposed project has the potential to enhance the current VA standard of care as well as to add to the scientific literature on psychological models and rehabilitation of chronic pain.
Interventions
8 group-administered sessions of Cognitive-Behavioral Therapy; includes relaxation, cognitive restructuring, and problem-solving
8 group-administered sessions of Acceptance-based therapy; includes mindfulness, values, and committed action
Sponsors
Study design
Eligibility
Inclusion criteria
* Age 18 years old or older; * Proficient in English; * Willing and able to provide written informed consent (proposed informed consent form attached as Appendix A); * Diagnosis of chronic benign pain as a secondary condition associated with a primary impairment due to a traumatic injury or congenital or acquired disorder as verified by a study physician after a medical diagnostic evaluation; * Average pain severity rated \> 4/10 with resulting functional limitations; and * Pain duration of at least 6 months.
Exclusion criteria
* Participation in psychotherapy for pain the past 2 months; * Serious, unstable medical illness for which inpatient hospitalization is likely over the next 3 months; and * The following DSM-IV diagnoses or active problems within the past 6 months noted in the patient's CPRS medical record or diagnosed during a structured psychiatric interview: 1) schizophrenia; 2) other psychotic disorder; 3) bipolar disorder; 4) organic mental disorder; 5) borderline or antisocial personality disorder; or 6) alcohol or substance abuse or dependence.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Brief Pain Inventory | 12 weeks (post treatment) | This questionnaire measures pain severity and interference. Scores range from 0-10, with higher scores indicating more pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| West Haven-Yale Multidimensional Pain Inventory - Activity Subscales | 12 weeks (post treatment) | This questionnaire measures levels of activity that can be affected by pain. Full measure has a range of 0-6, with higher scores indicating higher levels of activity. |
| SF-12 | 12 weeks (post treatment) | This questionnaire measures quality of life. Scores range from 0 to 100, with higher scores indicating better quality of life. |
| Beck Depression Inventory | 12 weeks (post treatment) | This questionnaire measures depressive symptoms. Scores range from 0 to 63, with higher scores indicating higher levels of depressive symptoms. |
| Pain Anxiety Symptom Scale - 20 | 12 weeks (post treatment) | This questionnaire measures pain-related anxiety. Scores range from 0 to 100, with higher scores indicating higher levels of anxiety. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Cognitive Behavioral Therapy 8 group-administered sessions of Cognitive-Behavioral Therapy
Cognitive-behavioral therapy: 8 group-administered sessions of Cognitive-Behavioral Therapy; includes relaxation, cognitive restructuring, and problem-solving | 57 |
| Acceptance-Based Therapy 8 group-administered sessions of Acceptance-based therapy
Acceptance-based therapy: 8 group-administered sessions of Acceptance-based therapy; includes mindfulness, values, and committed action | 57 |
| Total | 114 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lack of Efficacy | 0 | 2 |
| Overall Study | Protocol Violation | 3 | 2 |
| Overall Study | Withdrawal by Subject | 12 | 10 |
Baseline characteristics
| Characteristic | Cognitive Behavioral Therapy | Acceptance-Based Therapy | Total |
|---|---|---|---|
| Age, Continuous | 54.9 years STANDARD_DEVIATION 12.5 | 54.9 years STANDARD_DEVIATION 12.5 | 54.9 years STANDARD_DEVIATION 12.5 |
| Race/Ethnicity, Customized NonHispanic white | 38 participants | 39 participants | 77 participants |
| Race/Ethnicity, Customized Other | 19 participants | 18 participants | 37 participants |
| Region of Enrollment United States | 57 participants | 57 participants | 114 participants |
| Sex: Female, Male Female | 29 Participants | 29 Participants | 58 Participants |
| Sex: Female, Male Male | 28 Participants | 28 Participants | 56 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 50 | 0 / 49 |
| serious Total, serious adverse events | 0 / 50 | 0 / 49 |
Outcome results
Brief Pain Inventory
This questionnaire measures pain severity and interference. Scores range from 0-10, with higher scores indicating more pain.
Time frame: 12 weeks (post treatment)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Arm 1 | Brief Pain Inventory | 4.5 units on a scale | Standard Deviation 2.7 |
| Arm 2 | Brief Pain Inventory | 5.1 units on a scale | Standard Deviation 2.4 |
Beck Depression Inventory
This questionnaire measures depressive symptoms. Scores range from 0 to 63, with higher scores indicating higher levels of depressive symptoms.
Time frame: 12 weeks (post treatment)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Arm 1 | Beck Depression Inventory | 13.2 units on a scale | Standard Deviation 11.1 |
| Arm 2 | Beck Depression Inventory | 17.8 units on a scale | Standard Deviation 12.2 |
Pain Anxiety Symptom Scale - 20
This questionnaire measures pain-related anxiety. Scores range from 0 to 100, with higher scores indicating higher levels of anxiety.
Time frame: 12 weeks (post treatment)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Arm 1 | Pain Anxiety Symptom Scale - 20 | 37.9 units on a scale | Standard Deviation 20.7 |
| Arm 2 | Pain Anxiety Symptom Scale - 20 | 41.5 units on a scale | Standard Deviation 23.4 |
SF-12
This questionnaire measures quality of life. Scores range from 0 to 100, with higher scores indicating better quality of life.
Time frame: 12 weeks (post treatment)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Arm 1 | SF-12 | 44.9 units on a scale | Standard Deviation 12.1 |
| Arm 2 | SF-12 | 41.0 units on a scale | Standard Deviation 13.6 |
West Haven-Yale Multidimensional Pain Inventory - Activity Subscales
This questionnaire measures levels of activity that can be affected by pain. Full measure has a range of 0-6, with higher scores indicating higher levels of activity.
Time frame: 12 weeks (post treatment)
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Arm 1 | West Haven-Yale Multidimensional Pain Inventory - Activity Subscales | 2.3 units on a scale | Standard Deviation 0.8 |
| Arm 2 | West Haven-Yale Multidimensional Pain Inventory - Activity Subscales | 2.0 units on a scale | Standard Deviation 0.8 |